Literature DB >> 8057800

Quantitative MRI of Gd-DTPA uptake in tumors: response to photodynamic therapy.

S D Kennedy1, L S Szczepaniak, S L Gibson, R Hilf, T H Foster, R G Bryant.   

Abstract

A partial saturation method is described for obtaining rapid images of tissue 1H spin-lattice relaxation rates following administration of the paramagnetic contrast agent gadolinium-diethylenetriaminepentaacetate. The paramagnetic contribution to the relaxation rates is proportional to the concentration of contrast agent, making possible quantitative studies of paramagnetic contrast agent uptake or vessel leakage. Snapshot imaging capabilities are not required. Maps of contrast agent uptake rates are made in rat borne tumors before and following photodynamic therapy, which is known to cause vascular damage. Uptake efficiency is spatially heterogeneous before and after therapy. Decreases in uptake rate are observed after two photo-irradiation protocols, which differ by a factor of four in fluence rate but deliver the same total fluence. There is no apparent fluence rate dependence for changes in the uptake rates within 5 h after therapy. Whole tumor measurements of nucleotide triphosphates, inorganic phosphate, pH, and lactate made with NMR spectroscopy indicate that, while net ATP production is inhibited, lactate concentrations are not strongly affected by photodynamic therapy. The ratio of nucleotide triphosphates to inorganic phosphate falls to 0.21 +/- 0.02 of initial values 5 h after tumors are treated with the lower fluence rate protocol, and falls to 0.40 +/- 0.06 in tumors treated with the higher fluence rate.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8057800     DOI: 10.1002/mrm.1910310308

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  9 in total

1.  Determination of in vivo rat muscle Gd-DTPA relaxivity at 6.3 T.

Authors:  T H Rozijn; B P van der Sanden; A Heerschap; J H Creyghton; W M Boveé
Journal:  MAGMA       Date:  1999-10       Impact factor: 2.310

2.  Dynamic contrast-enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF7 human breast tumors.

Authors:  E Furman-Haran; R Margalit; D Grobgeld; H Degani
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  Diffusion-weighted MRI for monitoring tumor response to photodynamic therapy.

Authors:  Hesheng Wang; Baowei Fei
Journal:  J Magn Reson Imaging       Date:  2010-08       Impact factor: 4.813

4.  In Vivo Small Animal Imaging for Early Assessment of Therapeutic Efficacy of Photodynamic Therapy for Prostate Cancer.

Authors:  Baowei Fei; Hesheng Wang; Xiang Chen; Joseph Meyers; John Mulvihill; Denise Feyes; Nancy Edgehouse; Jeffrey L Duerk; Thomas G Pretlow; Nancy L Oleinick
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2007-03-29

5.  High-field magnetic resonance imaging of the response of human prostate cancer to Pc 4-based photodynamic therapy in an animal model.

Authors:  Baowei Fei; Hesheng Wang; Joseph D Meyers; Denise K Feyes; Nancy L Oleinick; Jeffrey L Duerk
Journal:  Lasers Surg Med       Date:  2007-10       Impact factor: 4.025

6.  Early detection of tumour immune-rejection using magnetic resonance imaging.

Authors:  D-E Hu; D A Beauregard; M C Bearchell; L L Thomsen; K M Brindle
Journal:  Br J Cancer       Date:  2003-04-07       Impact factor: 7.640

7.  Quantitative Multi-Parametric Magnetic Resonance Imaging of Tumor Response to Photodynamic Therapy.

Authors:  Tom J L Schreurs; Stefanie J Hectors; Igor Jacobs; Holger Grüll; Klaas Nicolay; Gustav J Strijkers
Journal:  PLoS One       Date:  2016-11-07       Impact factor: 3.240

8.  Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic status.

Authors:  D A Beauregard; P E Thelwall; D J Chaplin; S A Hill; G E Adams; K M Brindle
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

9.  Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging.

Authors:  Henriette S de Bruijn; Vida Mashayekhi; Tom J L Schreurs; Pieter B A A van Driel; Gustav J Strijkers; Paul J van Diest; Clemens W G M Lowik; Ann L B Seynhaeve; Timo L M Ten Hagen; Jeanine J Prompers; Paul M P van Bergen En Henegouwen; Dominic J Robinson; Sabrina Oliveira
Journal:  Theranostics       Date:  2020-01-20       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.